Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia
Clinical Microbiology and Infection, 04/17/2012
Teh B et al. – Authors assessed the comparative efficacy of empirical therapy with beta–lactam plus macrolide vs. beta–lactam plus doxycycline for the treatment of community–acquired pneumonia (CAP) among patients in the Australian Community–Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either ‘atypical’ or typical bacterial pathogens.